FDA’s Botched Review of Moderna’s Flu mRNA Vaccine
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.3 Articles
3 Articles
Report: FDA’s Review of Moderna’s mRNA Flu Vaccine Concealed Statistically Significant Safety Signal
The Food and Drug Administration (FDA) on Aug. 6 licensed Moderna’s mRNA influenza vaccine, mFLUSIVA, for adults 50 and older – marking the first time the agency has approved an mRNA shot for seasonal flu, according to a company statement cited by the Epoch Times [1]. But an investigation by investigative reporter Maryanne Demasi published by Children’s […]
29 unexplained or sudden deaths under Moderna's mRNA flu vaccine, twelve in the comparator groups, not a single autopsy in the late Moderna subjects – and yet the FDA gives the green light. Severe systemic vaccine reactions also occurred more than six times as often as in the conventional comparator. What should actually be the reason for a new pharmaceutical technology for particularly accurate testing, is now being continued after approval – p…
FDA’s botched review of Moderna’s flu mRNA vaccine
Investigation into clinical trial documents reveals the FDA used statistical sleight of hand to make a serious safety signal in Moderna’s flu vaccine disappear By Maryanne Demasi, PhD · MD REPORTS · August 10, 2026 When the FDA licensed Moderna’s new mRNA flu vaccine last week, legacy media coverage focused almost exclusively on efficacy. The pivotal trial reported that the vaccine was “26.6% more effective” than a conventional flu vaccine at p…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
